This cancer type (hereafter BRCA1-associated breast cancer) is often diagnosed as having a triple-negative phenotype, which is characterized by a low or null level of expression of estrogen receptor α (ERα), progesterone receptor, and epidermal growth factor receptor 2, and/or a basal-like molecular subtype, expressing basal cell markers6. This evidence concerns the gene BRCA1 and cancer.